Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl

Joe Papa, President and CEO of Emergent BioSolutions

“On behalf of the Board of Directors and our colleagues, I want to thank Rich for his exceptional leadership, partnership and commitment to Emergent, and importantly, his dedication to our mission to protect and save lives”

Joe Papa, President and CEO of Emergent BioSolutions

“We are grateful that he will continue to advise the Company during the first quarter of 2027 as we complete this transition, and we wish him all the best in retirement. Since joining Emergent in 2019, Frank has been integral in driving our strategic priorities forward, and I am confident he will ensure continuity and disciplined financial stewardship as interim chief financial officer.”

Richard S. Lindahl, Executive Vice President and CFO of Emergent BioSolutions

“During my nearly nine years at Emergent, I am proud of the contributions our team made to the Company’s growth, the resilience we demonstrated through some extraordinarily challenging periods, and the progress we made in strengthening the business for the future”

Richard S. Lindahl, Executive Vice President and CFO of Emergent BioSolutions

“I am deeply grateful to the Board, my colleagues and the many people across Emergent who made this such a rewarding chapter of my career, and I am committed to ensuring a smooth and successful transition. Looking ahead, I am excited to remain professionally engaged through board service and advisory work while making more time for family, friends, travel and personal pursuits.”